- Home
- YRD vs CMPX Comparison
YRD vs CMPX Comparison
Compare YRD & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YRD
- CMPX
- Stock Information
- Founded
- YRD 2012
- CMPX 2014
- Country
- YRD China
- CMPX United States
- Employees
- YRD N/A
- CMPX N/A
- Industry
- YRD Finance: Consumer Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- YRD Finance
- CMPX Health Care
- Exchange
- YRD Nasdaq
- CMPX Nasdaq
- Market Cap
- YRD 532.3M
- CMPX 576.5M
- IPO Year
- YRD 2015
- CMPX N/A
- Fundamental
- Price
- YRD $6.41
- CMPX $3.65
- Analyst Decision
- YRD
- CMPX Strong Buy
- Analyst Count
- YRD 0
- CMPX 7
- Target Price
- YRD N/A
- CMPX $14.71
- AVG Volume (30 Days)
- YRD 93.0K
- CMPX 1.7M
- Earning Date
- YRD 11-19-2025
- CMPX 11-11-2025
- Dividend Yield
- YRD 6.90%
- CMPX N/A
- EPS Growth
- YRD N/A
- CMPX N/A
- EPS
- YRD 2.07
- CMPX N/A
- Revenue
- YRD $856,794,857.00
- CMPX N/A
- Revenue This Year
- YRD N/A
- CMPX N/A
- Revenue Next Year
- YRD N/A
- CMPX N/A
- P/E Ratio
- YRD $3.18
- CMPX N/A
- Revenue Growth
- YRD 12.42
- CMPX N/A
- 52 Week Low
- YRD $4.41
- CMPX $1.27
- 52 Week High
- YRD $8.74
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- YRD 64.07
- CMPX 56.88
- Support Level
- YRD $5.89
- CMPX $3.31
- Resistance Level
- YRD $6.07
- CMPX $3.80
- Average True Range (ATR)
- YRD 0.16
- CMPX 0.24
- MACD
- YRD 0.06
- CMPX -0.01
- Stochastic Oscillator
- YRD 67.62
- CMPX 70.51
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.